Kato Kazuya, Iwasaki Yoshiaki, Taniguchi Masahiko, Onodera Kazuhiko, Matsuda Minoru, Kawakami Takako, Higuchi Mineko, Kato Kimitaka, Kato Yurina, Furukawa Hiroyuki
Department of Surgery, Pippu Clinic, 2-10, 1 cyome Nakamachi, Pippu Town Kamikawa-gun, Hokkaido 078-0343, Japan.
Department of Gastroenterology and Hepatology, Okayama University, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558,Japan.
Int J Surg Case Rep. 2015;6C:95-9. doi: 10.1016/j.ijscr.2014.11.072. Epub 2014 Dec 4.
Protein induced by vitamin K absence/antagonist-II (PIVKA-II) is an abnormal protein, and several reports have demonstrated the efficacy of PIVKA-II in the diagnosis of hepatocellular carcinoma (HCC). We report an extremely rare case of adenocarcinoma of the colon with a high serum PIVKA-II level.
A 95-year-old woman presented with right lower quadrant pain and appetite loss. An abdominal computed tomography scan and ultrasonography showed an ascending colon tumor and multiple metastatic tumors in the liver. The serum level of PIVKA-II was extremely high, 11,900ng/mL. Colonoscopic examination revealed a tumor accompanied by an ulcer in the ascending colon, which was highly suspicious for malignancy. Multiple biopsies showed well-differentiated adenocarcinoma of the colon, which was evaluated as colon cancer, stage IV. PIVKA-II-productive colon cancer was confirmed. Chemotherapy with TS-1 was administered. The patient died 3 months after initial admission.
The expression of PIVKA-II was detected in non-cancer areas, with non-specific expression observed in plasma cells in our case. There might be some possibility that hepatoid differentiation exists in other regions of the colon tumor or in the liver tumor, parenchymal cells or lung metastases, which were composed of PIVKA-II-positive and AFP-negative cells.
To the best of our knowledge, high serum levels of PIVKA-II resulting from colon adenocarcinoma have not been reported previously. We report this rare case together with a review of the literature.
维生素K缺乏/拮抗剂-II诱导蛋白(PIVKA-II)是一种异常蛋白,多项报告已证实PIVKA-II在肝细胞癌(HCC)诊断中的有效性。我们报告了一例血清PIVKA-II水平高的极为罕见的结肠腺癌病例。
一名95岁女性因右下腹疼痛和食欲减退就诊。腹部计算机断层扫描和超声检查显示升结肠肿瘤及肝脏多发转移瘤。血清PIVKA-II水平极高,达11,900ng/mL。结肠镜检查发现升结肠有一伴有溃疡的肿瘤,高度怀疑为恶性。多次活检显示为高分化结肠腺癌,评估为结肠癌IV期。确诊为产生PIVKA-II的结肠癌。给予替吉奥化疗。患者在初次入院3个月后死亡。
在非癌区域检测到PIVKA-II的表达,在我们的病例中浆细胞出现非特异性表达。结肠肿瘤的其他区域或肝肿瘤、实质细胞或肺转移灶中可能存在肝样分化,这些区域由PIVKA-II阳性和甲胎蛋白阴性细胞组成。
据我们所知,此前尚未有结肠腺癌导致血清PIVKA-II水平升高的报告。我们报告这一罕见病例并对文献进行综述。